Drug Development

1 article tagged “Drug Development”

Learn

Aviva AVA-291: Aromatization-Resistant Testosterone for Women

Aviva Bio's AVA-291 is a deuterium-modified testosterone designed to resist aromatization and lower breast-cancer-cell-proliferation signal by approximately 1,000-fold.

All Topics

Women's HRT(44)Protocols(35)Menopause(33)Treatments(30)Safety(25)HRT(19)Womens Hrt(15)Comparisons(14)Perimenopause(14)Clinical Evidence(13)Dosing(13)Lab Testing(13)Timeline & Results(13)Fundamentals(13)Hormones(12)Clinics(12)Side Effects(9)Cardiovascular(9)Regulation(8)Research(8)Results(8)Estradiol(7)Monitoring(7)Access(7)Symptoms(6)Estrogen(6)Treatment(5)Fda(5)Mental Health(5)News(5)Mood(5)Libido(5)Body Composition(5)Sleep(4)Optimization(4)Musculoskeletal(4)Hot Flashes(4)Fertility(4)Injections(4)DHT(3)Prostate(3)Diagnosis(3)Blood Work(3)Clinical Trials(3)Enclomiphene(3)Weight Loss(3)Cost(3)Pricing(3)Telehealth(3)Peptides(3)Injection Sites(2)Troubleshooting(2)2026 Research(2)Gsm(2)Vaginal Estrogen(2)Anxiety(2)Surgery(2)Skin(2)Sarcopenia(2)Joint Pain(2)Testosterone(2)Insomnia(2)Nonhormonal(2)Vasomotor Symptoms(2)Breast Cancer(2)Bloodwork(2)2026(2)Timing(2)Free Testosterone(2)Shbg(2)Womens Health(2)Bone Health(2)Oral TRT(2)Cypionate(2)Pellets(2)Stacks(2)Progesterone(2)Hematocrit(2)Insurance(2)Shortage(2)Testing(2)HCG(2)Reviews(2)Management(2)